TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26041510

Group type: EXPERIMENTAL
Intervention: Knee OA-insomnia group
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Low sleep efficiency and high catastrophizing scores
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Central sensitization (CS)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Overall sample
Number of subjects: 208
Study: 22491388

Group type: EXPERIMENTAL
Intervention: Educational materials for bottle weaning
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nutritional counseling sessions with educational materials
Number of subjects: 26
Study: 21224234

Group type: EXPERIMENTAL
Intervention: 2 g of l‐carnitine‐l‐tartrate and 80 g of CHO (Carnitine)
Number of subjects: 14

Group type: COMPARATOR
Intervention: 80 g of CHO (Control)
Number of subjects: 14
Study: 19545216

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 0

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 0
Study: 18184521

Group type: EXPERIMENTAL
Intervention: Sevelamer carbonate
Number of subjects: 79

Group type: COMPARATOR
Intervention: Sevelamer hydrochloride
Number of subjects: 79
Study: 15058097

Group type: EXPERIMENTAL
Intervention: Before-Discharge Intervention Method (BDIM)
Number of subjects: 0
Study: 15333727

Group type: EXPERIMENTAL
Intervention: 5 d/wk iron supplementation (Ferrous sulfate 300 mg)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: 1 d/wk iron supplementation (Ferrous sulfate 300 mg)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 397
Study: 10359248

Group type: EXPERIMENTAL
Intervention: Transected humeral insertion (n = 29)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intact humeral insertion (n = 31)
Number of subjects: 60
Study: 7866806

Group type: EXPERIMENTAL
Intervention: sulglycotide 200 mg twice daily
Number of subjects: 119

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 119
Study: 1784010

Group type: EXPERIMENTAL
Intervention: Bio-Dis apparatus
Number of subjects: 3

Group type: COMPARATOR
Intervention: Rotating bottle method
Number of subjects: 3
Study: 7058815

Group type: COMPARATOR
Intervention: Keflin®, gentamicin and carbenicillin (KGC)
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: KGC
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: KGC plus empiric amphotericin B
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: KGC plus amphotericin B
Number of subjects: 271
Study: 31542382

Group type: EXPERIMENTAL
Intervention: Structured sorting task for classifying dishes based on healthiness and hedonic perception
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Age groups (6-7 years and 8-9 years)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Overall study findings
Number of subjects: 277
Study: 30447565

Group type: EXPERIMENTAL
Intervention: Sertraline - Clinical Management (CM)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Pill Placebo - Clinical Management (CM)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: All conditions (IPT, Sertraline-CM, Pill Placebo-CM)
Number of subjects: 162
Study: 29478425

Group type: EXPERIMENTAL
Intervention: Day hospital mentalization-based treatment (MBT-DH)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Specialist treatment as usual (S-TAU)
Number of subjects: 95
Study: 26199066

Group type: EXPERIMENTAL
Intervention: Robotic navigation system (RNS) for circumferential pulmonary vein isolation (CPVI)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Manual ablation
Number of subjects: 200
Study: 24612221

Group type: EXPERIMENTAL
Intervention: Vildagliptin (50 mg BID)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 22745277

Group type: EXPERIMENTAL
Intervention: Exit site infection (ESI)
Number of subjects: 203

Group type: COMPARATOR
Intervention: No recent exit site infection (control group)
Number of subjects: 203
Study: 20570971

Group type: EXPERIMENTAL
Intervention: Office hysteroscopy
Number of subjects: 678
Study: 17903157

Group type: EXPERIMENTAL
Intervention: Endovenous laser (EVL) treatment with a 980‐nm diode, plus clinical treatment
Number of subjects: 52

Group type: COMPARATOR
Intervention: Clinical treatment (elastic or inelastic compression therapy)
Number of subjects: 52
Study: 16086896

Group type: EXPERIMENTAL
Intervention: Atovaquone/proguanil (A/P)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 12297759

Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 30
Study: 11692348

Group type: EXPERIMENTAL
Intervention: Tramadol drops 3 mg/kg plus oral midazolam 0.5 mg/kg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (no tramadol)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Tramadol drops 3 mg/kg
Number of subjects: 50
Study: 7564670

Group type: EXPERIMENTAL
Intervention: Terlipressin combined with glyceryl trinitrate (TER-GTN), intravenous injection (1 to 2 mg)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Double-placebo injection
Number of subjects: 76
Study: 31351062

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound + CA125 + human epididymis 4
Number of subjects: 1590

Group type: COMPARATOR
Intervention: Transvaginal ultrasound + CA125
Number of subjects: 1590
Study: 31651877

Group type: EXPERIMENTAL
Intervention: High-dimensional test for treatment effects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional test for treatment effects
Number of subjects: 0
Study: 28399825

Group type: EXPERIMENTAL
Intervention: Obese mothers
Number of subjects: 139

Group type: COMPARATOR
Intervention: Overweight/normal weight mothers
Number of subjects: 139

Group type: COMPARATOR
Intervention: Infants
Number of subjects: 139
Study: 26163250

Group type: EXPERIMENTAL
Intervention: Itraconazole (1 month preoperative)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (no preoperative itraconazole)
Number of subjects: 27
Study: 26030981

Group type: COMPARATOR
Intervention: Pathway 1 FTCs facilitated by case-workers
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Pathway 2 FTCs co-facilitated by caseworkers and a designated/trained facilitator
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Pathway 3 FTCs with family alone time
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Pathway 2 and Pathway 3 FTCs
Number of subjects: 623
Study: 21704557

Group type: EXPERIMENTAL
Intervention: Morning blue light (470nm, ∼225lux, n=12)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Dim light (<1lux, n=13)
Number of subjects: 25
Study: 19388972

Group type: EXPERIMENTAL
Intervention: Nateglinide (120 mg three times daily)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 16816796

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 1460

Group type: COMPARATOR
Intervention: Perphenazine
Number of subjects: 1460

Group type: COMPARATOR
Intervention: Quetiapine
Number of subjects: 1460

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 1460

Group type: COMPARATOR
Intervention: Ziprasidone
Number of subjects: 1460
Study: 15283897

Group type: EXPERIMENTAL
Intervention: Screening for prostate, lung, colon, and ovarian cancer
Number of subjects: 155000

Group type: COMPARATOR
Intervention: Control participants (not specified)
Number of subjects: 155000
Study: 11321633

Group type: EXPERIMENTAL
Intervention: Simulated and real planes slant judgments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Texture gradients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Response method
Number of subjects: 0
Study: 9253686

Group type: EXPERIMENTAL
Intervention: Spirometric control during IG test
Number of subjects: 19

Group type: COMPARATOR
Intervention: Uncontrolled IG test
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Inspiration as fast as possible
Number of subjects: 19

Group type: COMPARATOR
Intervention: Inspiration in 5 seconds
Number of subjects: 19

Group type: COMPARATOR
Intervention: Inspiration in 10 seconds
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Continuously sucking negative mouth pressure
Number of subjects: 19

Group type: COMPARATOR
Intervention: Taking one deep breath and holding it for 10 seconds
Number of subjects: 19
Study: 8318601

Group type: EXPERIMENTAL
Intervention: 3-in-1 catheter group (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3-in-1 catheter group
Number of subjects: 40
Study: 3525684

Group type: EXPERIMENTAL
Intervention: Adjuvant systemic antibiotic therapy
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 31894620

Group type: EXPERIMENTAL
Intervention: Healthcare utilisation from general hospitals
Number of subjects: 1812
Study: 30178600

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (5 mg/d)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 57
Study: 27918670

Group type: EXPERIMENTAL
Intervention: Combined plyometric and strength training (PLY+ST)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Strength training only (ST)
Number of subjects: 18
Study: 26375964

Group type: EXPERIMENTAL
Intervention: Home visit
Number of subjects: 4481

Group type: COMPARATOR
Intervention: Well-baby clinic visit
Number of subjects: 4481
Study: 23939512

Group type: EXPERIMENTAL
Intervention: Yohimbine HCL (single administration paired with the first session of imaginal exposure)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Yohimbine HCL and PE
Number of subjects: 40
Study: 22110589

Group type: EXPERIMENTAL
Intervention: 500 ml orange juice daily for 4 weeks
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 500 ml control drink plus hesperidin daily for 4 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: 500 ml control drink and placebo daily for 4 weeks
Number of subjects: 10
Study: 19089777

Group type: EXPERIMENTAL
Intervention: Misoprostol (600 microg)
Number of subjects: 1620

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1620
Study: 16923110

Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (other therapies)
Number of subjects: 25
Study: 14738099

Group type: EXPERIMENTAL
Intervention: Terbinafine
Number of subjects: 13

Group type: COMPARATOR
Intervention: Itraconazole
Number of subjects: 13
Study: 10912889

Group type: EXPERIMENTAL
Intervention: 10% maltodextrin solution (Md)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 8
Study: 9020538

Group type: COMPARATOR
Intervention: Class I alcohol dehydrogenase isoenzymes activity during hospitalization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Class II alcohol dehydrogenase isoenzymes activity during hospitalization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Activity of alcohol dehydrogenase isoenzymes over time
Number of subjects: 0

Group type: COMPARATOR
Intervention: Correlation of alcohol dehydrogenase isoenzymes with other liver enzymes
Number of subjects: 0
Study: 18796776

Group type: EXPERIMENTAL
Intervention: Feldenkrais Awareness Through Movement sequence
Number of subjects: 30
Study: 3919917

Group type: EXPERIMENTAL
Intervention: Intravenous hyperalimentation (IVH) for 30 days
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group (no IVH)
Number of subjects: 119
Study: 29172594

Group type: EXPERIMENTAL
Intervention: Brief motivational interventions (BMIs)
Number of subjects: 252
Study: 27010683

Group type: EXPERIMENTAL
Intervention: 400 mg/day of study medication
Number of subjects: 0

Group type: COMPARATOR
Intervention: 50 mg/day of study medication (control)
Number of subjects: 0
Study: 26311347

Group type: EXPERIMENTAL
Intervention: Fasting in the follicular phase
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Fasting in the luteal phase
Number of subjects: 7

Group type: COMPARATOR
Intervention: Meal intake in the follicular phase
Number of subjects: 7

Group type: COMPARATOR
Intervention: Meal intake in the luteal phase
Number of subjects: 7
Study: 24645337

Group type: EXPERIMENTAL
Intervention: Symptom monitoring plus feedback (SM + F; n = 49)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Usual care (UC; n = 45)
Number of subjects: 94
Study: 21605396

Group type: EXPERIMENTAL
Intervention: Fluticasone/formoterol
Number of subjects: 202

Group type: COMPARATOR
Intervention: Fluticasone/salmeterol
Number of subjects: 202
Study: 18463429

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (selenium, vitamin C, and folate) for 8 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 17030973

Group type: EXPERIMENTAL
Intervention: Culturally proficient 14-week diet/physical activity intervention (three times weekly)
Number of subjects: 12

Group type: COMPARATOR
Intervention: General health intervention (control)
Number of subjects: 12
Study: 15295782

Group type: EXPERIMENTAL
Intervention: Soft gelatin capsules with vitamin E TPGS (5 mg strength)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Soft gelatin capsules without vitamin E TPGS (5 mg strength)
Number of subjects: 0
Study: 11890241

Group type: EXPERIMENTAL
Intervention: Intervention group (active patient participation in treatment choice)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group (standardized treatment protocols)
Number of subjects: 210
Study: 9598228

Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene (PTFE) surgical membrane
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Biodegradable polyglycolic acid (PGA) mesh
Number of subjects: 540
Study: 7530121

Group type: EXPERIMENTAL
Intervention: Alfuzosin for 24 months (n = 50)
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Alfuzosin for 30 months (n = 22)
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Alfuzosin (long-term treatment)
Number of subjects: 518

Group type: COMPARATOR
Intervention: Placebo (initial randomization)
Number of subjects: 518
Study: 3057844

Group type: EXPERIMENTAL
Intervention: Propafenone 337.5 mg/day
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Propafenone 450 mg/day
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Propafenone 675 mg/day
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Propafenone 900 mg/day
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Propafenone (all doses)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 226
Study: 30558034

Group type: EXPERIMENTAL
Intervention: Fascia lata allograft
Number of subjects: 44

Group type: COMPARATOR
Intervention: Gracilis tendon autograft
Number of subjects: 44
Study: 27716297

Group type: EXPERIMENTAL
Intervention: Motivational intervention
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Pedometer intervention
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 394

Group type: COMPARATOR
Intervention: Control (Health Check only)
Number of subjects: 394
Study: 24878943

Group type: EXPERIMENTAL
Intervention: Intradialytic exercise (30 minutes per dialysis session, 3 times a week for 3 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 40
Study: 22402204

Group type: EXPERIMENTAL
Intervention: Interferon beta
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Interferon beta and low‐dose azathioprine
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Interferon beta, azathioprine and low‐dose prednisone
Number of subjects: 181
Study: 19918196

Group type: EXPERIMENTAL
Intervention: Stretching (16 minutes of static stretching using 5 exercises for the major lower body muscle groups)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nonstretching (16 minutes of quiet sitting)
Number of subjects: 10
Study: 18164827

Group type: COMPARATOR
Intervention: Media resistance skills
Number of subjects: 1318

Group type: COMPARATOR
Intervention: Drug skill refusal techniques
Number of subjects: 1318

Group type: COMPARATOR
Intervention: Baseline media resistance skills
Number of subjects: 1318
Study: 16357552

Group type: EXPERIMENTAL
Intervention: Low-dose botulinum toxin (100 units) with short-term electrical stimulation
Number of subjects: 12

Group type: COMPARATOR
Intervention: High-dose botulinum toxin (400 units)
Number of subjects: 12
Study: 12791549

Group type: EXPERIMENTAL
Intervention: Exposure Prevention rating method
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Inter-rater reliability assessment by a second hygienist
Number of subjects: 131
Study: 11305382

Group type: EXPERIMENTAL
Intervention: Mometasone furoate fatty cream, applied twice weekly for 6 months
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Mometasone furoate fatty cream
Number of subjects: 68
Study: 8975837

Group type: EXPERIMENTAL
Intervention: Postoperative low-dose aprotinin (2 million kallikrein inactivator units)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 1535579

Group type: EXPERIMENTAL
Intervention: Roxithromycin 150 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Roxithromycin 300 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Clarithromycin 250 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Clarithromycin 500 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Roxithromycin vs Clarithromycin
Number of subjects: 12
Study: 6142218

Group type: EXPERIMENTAL
Intervention: Amantadine (100 mg daily)
Number of subjects: 267

Group type: COMPARATOR
Intervention: No specific treatment (Control)
Number of subjects: 267
Study: 31928270

Group type: EXPERIMENTAL
Intervention: New reference values for third-trimester amniotic fluid index (AFI)
Number of subjects: 7037

Group type: COMPARATOR
Intervention: Comparison with previously published normograms
Number of subjects: 7037
Study: 31426450

Group type: EXPERIMENTAL
Intervention: Multiple Traffic Lights (MTL)
Number of subjects: 12015

Group type: COMPARATOR
Intervention: Health Star Rating (HSR)
Number of subjects: 12015

Group type: COMPARATOR
Intervention: Nutri-Score
Number of subjects: 12015

Group type: COMPARATOR
Intervention: Reference Intakes (RI)
Number of subjects: 12015

Group type: COMPARATOR
Intervention: Warning Label
Number of subjects: 12015
Study: 30190053

Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP) treatment, 12 weekly sessions
Number of subjects: 64

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 64
Study: 27391572

Group type: EXPERIMENTAL
Intervention: SQ-LNS
Number of subjects: 1320

Group type: COMPARATOR
Intervention: IFA
Number of subjects: 1320

Group type: COMPARATOR
Intervention: MMN
Number of subjects: 1320
Study: 24603844

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Excluding weekends
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Using 4 weekdays
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Using 5 weekdays
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Excluding days with < 8 h wearing time
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Considering the difference in daylight time (DT) as a covariate
Number of subjects: 57
Study: 21982055

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 755 nm laser therapy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Epidermal abrasion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tacrolimus cream
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Local steroids
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream
Number of subjects: 12
Study: 20738062

Group type: EXPERIMENTAL
Intervention: Nurse-led community care program (Network Collaborative Action Plan - N-CAP)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (historical controls)
Number of subjects: 91
Study: 18477082

Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 78

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 78
Study: 15909439

Group type: EXPERIMENTAL
Intervention: Topical negative pressure (TNP)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional therapy (moist gauze)
Number of subjects: 54
Study: 12878948

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (1 cycle of 5 minutes of ischemia/5 minutes of reperfusion) in group III (surgery on the beating heart)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning in vitro (5 minutes of ischemia and 5 minutes of reoxygenation before long ischemic insult)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no ischemic preconditioning) in vitro
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Muscles obtained 10 minutes after initiation of cardiopulmonary bypass
Number of subjects: 120
Study: 10537958

Group type: EXPERIMENTAL
Intervention: Continuous intrathecal baclofen infusion via a subcutaneously implanted programmable pump (SynchroMed, Medtronic)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Continuous intrathecal baclofen infusion
Number of subjects: 18
Study: 8679058

Group type: EXPERIMENTAL
Intervention: SF-36 Health Survey
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: SF-36 Mental Health Scale
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: SF-36 Mental Component Summary
Number of subjects: 532
Study: 1830108

Group type: EXPERIMENTAL
Intervention: Isradipine 2.5 mg twice daily
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Isradipine 5.0 mg once daily
Number of subjects: 32
Study: 3978012

Group type: EXPERIMENTAL
Intervention: Ephedrine i.v. to maintain systolic arterial pressure at or above 100 mm Hg (Group A)
Number of subjects: 38

Group type: COMPARATOR
Intervention: No ephedrine (Group B)
Number of subjects: 38
Study: 31309868

Group type: EXPERIMENTAL
Intervention: Resistant starch-supplemented medium (RSM)
Number of subjects: 10
Study: 30048648

Group type: EXPERIMENTAL
Intervention: High intensity low volume (HILV) exercise
Number of subjects: 23

Group type: COMPARATOR
Intervention: Moderate continuous aerobic training (MCT)
Number of subjects: 23
Study: 27892423

Group type: EXPERIMENTAL
Intervention: mobile telemonitoring guided cardiac rehabilitation (mCR) - personalized home-based programme
Number of subjects: 238

Group type: COMPARATOR
Intervention: no advice or coaching (Control)
Number of subjects: 238